Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arriagada, R.
Right arrow Articles by Rotstein, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arriagada, R.
Right arrow Articles by Rotstein, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Journal of Clinical Oncology, Vol 13, 2869-2878, Copyright © 1995 by American Society of Clinical Oncology


ARTICLES

Adequate locoregional treatment for early breast cancer may prevent secondary dissemination

R Arriagada, LE Rutqvist, A Mattsson, A Kramar and S Rotstein
Institut Gustave-Roussy, Villejuif, France.

PURPOSE: To analyze different events that determine event-free survival (EFS) in a randomized trial on adjuvant radiotherapy in early breast cancer patients with more than 15 years of follow-up evaluation. PATIENTS AND METHODS: The trial included 960 patients with a unilateral, operable breast cancer. Surgery consisted of a modified radical mastectomy. The trial compared three arms, as follows: preoperative radiotherapy, postoperative radiotherapy, and no adjuvant treatment. Events were analyzed by a competing-risk approach. A proportional hazards multiple regression model was used to analyze the effects of radiotherapy on the risk of distant metastasis. Similar analyses were performed separately for node-negative [N(-)] and node- positive [N(+)] patients in the two groups that did not include preoperative radiotherapy. RESULTS: Radiotherapy produced a fivefold decrease of the risk of local recurrence (P < .0001). In N(+) patients, postoperative radiotherapy decreased the risk of distant dissemination (relative risk, 0.63). When local recurrence was introduced in the model as a time-dependent covariate, this factor was predictive of distant dissemination (P < .0001) and nullified the effect of postoperative radiotherapy. This finding suggests that the decrease of distant metastases was related to the prevention of local recurrence. A similar effect was found in models that used overall survival as an end point. CONCLUSION: This study shows that postmastectomy radiotherapy in N(+) breast cancer patients may decrease the distant metastasis rate by preventing local recurrences and thus avoiding secondary dissemination.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
RadiologyHome page
H. J. Moon, M. J. Kim, E.-K. Kim, B.-W. Park, J. H. Youk, J. Y. Kwak, J. Sohn, and S.-I. Kim
US Surveillance of Regional Lymph Node Recurrence after Breast Cancer Surgery
Radiology, June 22, 2009; (2009) 2523081977.
[Abstract] [Full Text]


Home page
JCOHome page
H. M. Nielsen, M. Overgaard, C. Grau, A. R. Jensen, and J. Overgaard
Study of Failure Pattern Among High-Risk Breast Cancer Patients With or Without Postmastectomy Radiotherapy in Addition to Adjuvant Systemic Therapy: Long-Term Results From the Danish Breast Cancer Cooperative Group DBCG 82 b and c Randomized Studies
J. Clin. Oncol., May 20, 2006; 24(15): 2268 - 2275.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. Ragaz, I. A. Olivotto, J. J. Spinelli, N. Phillips, S. M. Jackson, Kenneth. S. Wilson, M. A. Knowling, C. M. L. Coppin, L. Weir, K. Gelmon, et al.
Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized Trial
J Natl Cancer Inst, January 19, 2005; 97(2): 116 - 126.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
J A Violet and C Harmer
Breast cancer: improving outcome following adjuvant radiotherapy
Br. J. Radiol., October 1, 2004; 77(922): 811 - 820.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
C. S. Hinrichs, N. L. Watroba, H. Rezaishiraz, W. Giese, T. Hurd, K. A. Fassl, and S. B. Edge
Lymphedema Secondary to Postmastectomy Radiation: Incidence and Risk Factors
Ann. Surg. Oncol., June 1, 2004; 11(6): 573 - 580.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
R. Arriagada, M. G. Le, J.-M. Guinebretiere, A. Dunant, F. Rochard, and T. Tursz
Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients
Ann. Onc., November 1, 2003; 14(11): 1617 - 1622.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. Huang, L. Barbera, M. Brouwers, G. Browman, and W. J. Mackillop
Does Delay in Starting Treatment Affect the Outcomes of Radiotherapy? A Systematic Review
J. Clin. Oncol., February 1, 2003; 21(3): 555 - 563.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
R. Arriagada, M. G. Le, G. Contesso, J. M. Guinebretiere, F. Rochard, and M. Spielmann
Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer
Ann. Onc., September 1, 2002; 13(9): 1404 - 1413.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. H. Lee, H. A. Glick, J. A. Hayman, and L. J. Solin
Decision-Analytic Model and Cost-Effectiveness Evaluation of Postmastectomy Radiation Therapy in High-Risk Premenopausal Breast Cancer Patients
J. Clin. Oncol., June 1, 2002; 20(11): 2713 - 2725.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C. Schmoor, W. Sauerbrei, G. Bastert, and M. Schumacher
Role of Isolated Locoregional Recurrence of Breast Cancer: Results of Four Prospective Studies
J. Clin. Oncol., April 1, 2000; 18(8): 1696 - 1708.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. Fortin, M. Larochelle, J. Laverdiere, S. Lavertu, and D. Tremblay
Local Failure Is Responsible for the Decrease in Survival for Patients With Breast Cancer Treated With Conservative Surgery and Postoperative Radiotherapy
J. Clin. Oncol., January 1, 1999; 17(1): 101 - 101.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. El-Tamer, P. Homel, A. S. Braverman, W. H. Wolberg, H. I. Robins, A. Goldhirsch, A. S. Coates, M. Colleoni, R. D. Gelber, A.E. Raffle, et al.
Radiotherapy and Chemotherapy in High-Risk Breast Cancer
N. Engl. J. Med., January 29, 1998; 338(5): 329 - 333.
[Full Text]


Home page
NEJMHome page
J. Ragaz, S. M. Jackson, N. Le, I. H. Plenderleith, J. J. Spinelli, V. E. Basco, K. S. Wilson, M. A. Knowling, C. M.L. Coppin, M. Paradis, et al.
Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast Cancer
N. Engl. J. Med., October 2, 1997; 337(14): 956 - 962.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 1995 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online